Composition
- Active ingredients
- MIRABEGRON 8MG/ML
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA213801.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Myrbetriq Granules
- Active substance
- mirabegron
- Route
- Oral
- Dosage form
- For suspension, extended release
- Applicant
- Apgdi
- Status
- Prescription
- FDA approval
- 25 Mar 2021
- Application
- NDA213801-001